Press releases
- Bruker Announces Acquisition of ACQUIFER Imaging GmbH
- Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers
- Bruker Corporation to Present at the 41st Annual J.P. Morgan Healthcare Conference
- Bruker Energy & Supercon Technologies (BEST) Announces Multi-Year Orders for Key Magnetic Confinement Fusion Technologies
- Functional precision oncology leader Kiyatec announces Series C round with US$18 million closing to accelerate adoption of transformational cancer platform
- Bruker Announces Agreement to Acquire Neurescence Inc., Bolstering Neuroscience Research Portfolio
- Bruker Announces Quarterly Dividend
- Bruker Announces Acquisition of Inscopix for Neuroscience Research
- Bruker Corporation to Participate in the 2022 Jefferies London Healthcare Conference
- Bruker Reports Third Quarter 2022 Financial Results
More ▼
Key statistics
On Monday, Bruker Corp (BKD:FRA) closed at 65.00, -5.80% below its 52-week high of 69.00, set on Nov 11, 2022.
52-week range
Markit short selling activity
Open | 66.00 |
---|---|
High | 66.00 |
Low | 65.00 |
Bid | -- |
Offer | -- |
Previous close | 65.00 |
Average volume | 10.55 |
---|---|
Shares outstanding | 147.08m |
Free float | 98.87m |
P/E (TTM) | 39.23 |
Market cap | 10.54bn USD |
EPS (TTM) | 1.83 USD |
Annual div (ADY) | 0.1922 EUR |
---|---|
Annual div yield (ADY) | 0.30% |
Div ex-date | Nov 30 2022 |
Div pay-date | Dec 16 2022 |
Data delayed at least 15 minutes, as of Jan 30 2023 12:28 GMT.
More ▼